Tag archive for ‘Amgen’
Amgen acquisition of Rodeo Therapeutics
By businessnewstoday On Wednesday, March 31st, 2021
0 Comments

Amgen to acquire Rodeo Therapeutics in $721m worth deal

(adsbygoogle = window.adsbygoogle || []).push({}); Amgen has agreed to acquire Rodeo Therapeutics, a Seattle-based biopharma company, in a deal worth up to $721 million. Rodeo Therapeutics is engaged More...

Amgen acquisition of Five Prime Therapeutics
By businessnewstoday On Thursday, March 4th, 2021
0 Comments

Amgen to acquire Five Prime Therapeutics for gastric cancer candidate bemarituzumab

Amgen acquisition of Five Prime Therapeutics : Amgen has agreed to acquire Five Prime Therapeutics, a clinical-stage biotech company, for about $1.9 billion, to add a phase 3 ready gastric cancer candidate called More...

By pharmanewsdaily On Sunday, January 31st, 2021
0 Comments

Amgen gets breakthrough therapy status for sotorasib in China

Amgen said that sotorasib, an investigational KRASG12C inhibitor, has been given breakthrough therapy designation (BTD) from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) More...

By pharmanewsdaily On Thursday, September 17th, 2020
0 Comments

Lilly, Amgen collaborate to boost supply of potential COVID-19 therapies

Eli Lilly and Company has entered into a global antibody manufacturing collaboration with Amgen to considerably boost the supply capacity for its potential COVID-19 therapies. Currently, Lilly is studying various More...

By pharmanewsdaily On Sunday, August 23rd, 2020
0 Comments

Janssen, Amgen secure FDA approval for DKd regiment in multiple myeloma

DKd regiment FDA approval for multiple myeloma : Janssen Pharmaceutical Companies of Johnson & Johnson and Amgen have been granted an expanded approval from the US Food and Drug Administration (FDA) for the More...

By pharmanewsdaily On Friday, December 20th, 2019
0 Comments

Amgen, Allergan file BLA to FDA for Rituxan biosimilar ABP 798

Rituxan biosimilar ABP 798 : US biopharma company Amgen and Irish pharma company Allergan have submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for ABP 798, a biosimilar More...

By pharmanewsdaily On Friday, November 22nd, 2019
0 Comments

Bristol-Myers Squibb wraps up $74bn acquisition of Celgene

Bristol-Myers Squibb has wrapped up its $74 billion acquisition of Celgene having got regulatory approval from all government authorities necessary for closing the merger agreement along with approvals from stockholders More...

By pharmanewsdaily On Sunday, November 17th, 2019
0 Comments

FTC clears decks for Bristol-Myers Squibb acquisition of Celgene

Bristol-Myers Squibb acquisition of Celgene : US pharma giant Bristol-Myers Squibb said that the US Federal Trade Commission (FTC) has given its clearance for its previously announced $74 billion acquisition of More...

By pharmanewsdaily On Tuesday, November 5th, 2019
0 Comments

Amgen to take 20.5% stake in Chinese biotech company BeiGene for $2.7bn

US biopharma company Amgen has signed an all-cash deal to acquire a 20.5% stake in Chinese biotech company BeiGene for about $2.7 billion, as per the latest pharma acquisition news. The Beijing-based BeiGene is More...

By pharmanewsdaily On Friday, September 13th, 2019
0 Comments

CANDOR clinical trial results : Amgen’s Kyprolis extends PFS in multiple myeloma patients

CANDOR clinical trial results : Amgen said that a phase 3 study assessing Kyprolis (carfilzomib) in combination with dexamethasone and Johnson & Johnson’s Darzalex (daratumumab) (KdD) compared to Kyprolis More...